Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2021 | Bringing clinical trials to communities

Melissa Johnson • 8 Jan 2021
WCLC 2021
General

Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, discusses the importance of bringing clinical trials to communities and engaging with community oncologists, outlining the strategies being implemented at the Sarah Cannon research Institute. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melissa Johnson

ADCs for lung cancer
1:49
ADCs for lung cancer
Melissa Johnson • 27 Feb 2023
Cellular therapies for NSCLC
1:30
Cellular therapies for NSCLC
Melissa Johnson • 27 Feb 2023
Targeting IL-2 in advanced NSCLC
3:46
Targeting IL-2 in advanced NSCLC
Melissa Johnson • 27 Feb 2023
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC
2:42
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC
Melissa Johnson • 15 Sep 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026
The content of VJOncology is intended for healthcare professionals